Be-Line Pharmaceuticals Private Limited, a active private limited company, was established on 13 December 1994 in Thanjavur, Tamil Nadu, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24231TN1994PTC029511. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.45 M.
It upholds a compliant status. Its leadership includes Sudharaman Sunilkumar (Director), Karunai Kadal (Director), Mohamed Farook (Director). Past directors included Sudharaman Sunilkumar, Mohamed Farook, Janardhanan. It holds ₹6.80 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at No.3306/66 Shanthi Nagar, Nk Road, Thanjavur, Tamil Nadu, 613006.
U24231TN1994PTC029511
029511
13 December 1994
₹0.50 M
₹0.45 M
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Be-Line Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sudharaman Sunilkumar | Director | 05 Apr 2012 | Current |
| Karunai Kadal | Director | 05 Apr 2012 | Current |
| Mohamed Farook | Director | 05 Apr 2012 | Current |
| Janardhanan | Director | 05 Apr 2012 | Current |
| Sarah Ramkumar | Director | 05 Apr 2012 | Current |
| Mohamed Kamaludeen Banufarook | Director | 14 Aug 1995 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 04 May 2021 | Past |
| Pramod Abcsdd | Director | 15 Mar 2021 | Past |
| Pramod Abcsdd | Director | 15 Mar 2021 | Past |
| Pramod Abcsdd | Director | 15 Mar 2021 | Past |
| Pramod Abcsdd | Director | 04 May 2021 | Past |
| Pramod Abcsdd | Director | 15 Mar 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Be-Line Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 32.85% increase. The company also saw a substantial fall in profitability, with a 12.57% decrease in profit. The company's net worth Soared by an impressive increase of 15.44%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Be-Line Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹6,800,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Oct 2021 | Vijaya Bank | ₹4.60 M | Open |
| 09 Mar 1998 | Vijaya Bank | ₹2.20 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Be-Line Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Be-Line Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Be-Line Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Be-Line Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity Be-Line Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai. was completed.
The activity A charge with Vijaya Bank amounted to Rs. 4.60 M with Charge ID 100490775 was registered on 22 Oct 2021. was completed.
A charge with Vijaya Bank of Rs. 2.20 M registered on 09 Mar 1998 with Charge ID 90283815 was modified on 28 Dec 2012. was recorded as a recent event.
Progress on Sudharaman Sunilkumar was appointed as a Director was appointed as a Director on 05 Apr 2012 & has been associated with this company since 13 years 8 months . was documented.
The activity Karunai Kadal was appointed as a Director was appointed as a Director on 05 Apr 2012 & has been associated with this company since 13 years 8 months . was completed.
The CIN of Be-Line Pharmaceuticals Private Limited is U24231TN1994PTC029511.
Be-Line Pharmaceuticals Private Limited is headquartered at No.3306/66 Shanthi Nagar, Nk Road, Thanjavur, Tamil Nadu, 613006.
Be-Line Pharmaceuticals Private Limited was incorporated on 13 December 1994.
The current directors of Be-Line Pharmaceuticals Private Limited are
The primary industry of Be-Line Pharmaceuticals Private Limited is Trade.
Be-Line Pharmaceuticals Private Limited is unlisted.
The authorized capital of Be-Line Pharmaceuticals Private Limited is ₹0.50 M, and the paid-up capital is ₹0.45 M.
The compliance status of Be-Line Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX